Medical Microbiology and Immunology

, Volume 199, Issue 2, pp 139–143 | Cite as

Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy

  • Tomas PalecekEmail author
  • Petr Kuchynka
  • Dagmar Hulinska
  • Jana Schramlova
  • Hana Hrbackova
  • Ivana Vitkova
  • Stanislav Simek
  • Jan Horak
  • William E. Louch
  • Ales Linhart
Rapid Communication


Dilated cardiomyopathy (DCM) represents the third most common cause of heart failure and the most frequent cause of heart transplantation. Infectious, mostly viral, and autoimmune mechanisms, together with genetic abnormalities, have been reported as three major causes of DCM. We hypothesized that Lyme disease (LD), caused by spirochete Borrelia burgdorferi (Bb), might be an important cause of new-onset unexplained DCM in patients living in a highly endemic area for LD such as the Czech Republic. We performed endomyocardial biopsy (EMB) in 39 consecutive patients presenting with symptomatic unexplained left ventricular (LV) systolic dysfunction lasting no more than 12 months. In eight subjects (21%), Bb was detected in the EMB sample by polymerase chain reaction or by electron microscopy. None of these patients exhibited any form of atrioventricular block or other extracardiac manifestation of Bb infection. Serological testing identified IgG antibodies against Bb in only two cases and IgM antibodies in none. All affected patients were treated with intravenous ceftriaxone for 3 weeks. At 6 months follow-up, LV morphology and function as well as functional status of these patients significantly improved. In conclusion, Bb infection may represent an important cause of new-onset unexplained DCM in patients living in endemic regions such as the Czech Republic. Because the antibiotic treatment appears to be markedly effective and serological examination does not provide a tool for diagnosing the disease, EMB focused on the detection of Bb should be performed in all patients from endemic areas with new-onset unexplained DCM not responding to conventional therapy.


Dilated cardiomyopathy Borrelia burgdorferi Endomyocardial biopsy Ceftriaxone 



Financial support by the Cardiovascular research project of the Charles University Prague, nr. 0021620817.


  1. 1.
    Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuwelt S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276CrossRefPubMedGoogle Scholar
  2. 2.
    Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of cardiomyopathies. Circulation 113:1807–1816CrossRefPubMedGoogle Scholar
  3. 3.
    Kühl U, Pauschinger M, Noutsias M, Kapp JF, Schultheiss HP (2002) Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J 4(Suppl I):I73–I80Google Scholar
  4. 4.
    Steere AC (2001) Lyme disease. N Engl J Med 345:115–125CrossRefPubMedGoogle Scholar
  5. 5.
    Cox J, Krajden M (1991) Cardiovascular manifestation of lyme disease. Am Heart J 122:1449–1455CrossRefPubMedGoogle Scholar
  6. 6.
    Bartunek P, Gorican K, Veiser T, Taborsky M, Hulinska D (2007) Significance of Borrelia infection in development of dilated cardiomyopathy (a pilot study). Prague Med Rep 108:339–347PubMedGoogle Scholar
  7. 7.
    Franz JK, Krause A (2003) Lyme disease (Lyme borreiolosis). Best Pract Res Clin Rheumatol 17:241–264CrossRefPubMedGoogle Scholar
  8. 8.
    Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography′s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMedGoogle Scholar
  9. 9.
    Weyman AE, Doty WD (1982) Left ventricle. In: Weyman AE (ed) Cross sectional echocardiography. Lea and Febiger, Philadelphia, p 267Google Scholar
  10. 10.
    Aretz HT (1987) Myocarditis: the dallas criteria. Hum Pathol 18:619–624CrossRefPubMedGoogle Scholar
  11. 11.
    Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic inflammatory process in dilated cardiomyopathy. Heart 75:295–300CrossRefPubMedGoogle Scholar
  12. 12.
    Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893CrossRefPubMedGoogle Scholar
  13. 13.
    Lelovas P, Donbas I, Bassiakou E, Xanthos T (2008) Cardiac implications of lyme disease, diagnosis and therapeutic approach. Int J Cardiol 129:15–21CrossRefPubMedGoogle Scholar
  14. 14.
    Pankuweit S, Hufnagel G, Eckhardt H, Hermann H, Uttecht S, Maisch B (1998) Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin (Munich) 93:223–228CrossRefGoogle Scholar
  15. 15.
    Rostoff P, Gajos G, Konduracka E, Gackowski A, Neseper J, Piwowarska W (2009) Lyme carditis: epidemiology, pathophysiology, and clinical features in endemic areas. Int J Cardiol. doi:  10.1016/j.ijcard.2009.03.034
  16. 16.
    Stanek G, Klein J, Bittner R, Glogar D (1990) Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322:249–252PubMedCrossRefGoogle Scholar
  17. 17.
    Suedkamp M, Lissel C, Eiffert H, Flesch M, Boehm M, Mehlhorn U, Thomssen R, de Vivie ER (1999) Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J 138:1198–1199CrossRefGoogle Scholar
  18. 18.
    Gasser R, Dusleag J, Reisinger E, Stauber R, Feigl B, Pongratz S, Klein W, Furian C, Pierer K (1992) Reversal by ceftriaxone of dilated cardiomyopathy borrelia burgdorferi infection. Lancet 339:1174–1175CrossRefPubMedGoogle Scholar
  19. 19.
    Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45CrossRefPubMedGoogle Scholar
  20. 20.
    Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863CrossRefPubMedGoogle Scholar
  21. 21.
    Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J (2005) Myocardial biopsy based classification and treatment in patiens with dilated cardiomyopathy. Int J Cardiol 104:92–100CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Tomas Palecek
    • 1
    • 6
    Email author
  • Petr Kuchynka
    • 1
  • Dagmar Hulinska
    • 2
  • Jana Schramlova
    • 2
  • Hana Hrbackova
    • 2
  • Ivana Vitkova
    • 3
  • Stanislav Simek
    • 1
  • Jan Horak
    • 1
  • William E. Louch
    • 4
    • 5
  • Ales Linhart
    • 1
  1. 1.1st Medical Faculty, 2nd Medical Department - Clinical Department of Cardiology and AngiologyCharles University of PraguePragueCzech Republic
  2. 2.National Institute of Public HealthPragueCzech Republic
  3. 3.1st Medical Faculty, Institute of PathologyCharles University of PraguePragueCzech Republic
  4. 4.Institute For Experimental Medical Research, Ullevaal University HospitalOsloNorway
  5. 5.Center For Heart Failure ResearchUniversity of OsloOsloNorway
  6. 6.2nd Medical Department - Clinical Department of Cardiology and AngiologyGeneral University HospitalPrague 2Czech Republic

Personalised recommendations